EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON

Phoom Narongkiatikhun iD, Petter Bjornstad iD

Kidney360 · 04.06.2026

DOI: 10.34067/kid.0000001278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.06.2026. Verfasst von Phoom Narongkiatikhun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, University of Washington School of Medicine, Seattle, WA, USA.
  • Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Phoom Narongkiatikhun, Petter Bjornstad

Zitieren

APA

Narongkiatikhun, P., & Bjornstad, P. (2026). Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON. Kidney360. https://doi.org/10.34067/kid.0000001278

Vancouver

Narongkiatikhun P, Bjornstad P. Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON. Kidney360. 2026. doi:10.34067/kid.0000001278

BibTeX
@article{Narongkiatikhun2026,
  author = {Narongkiatikhun, Phoom and Bjornstad, Petter},
  title = {Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: CON},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001278}
}
Kostenlos starten →